Core Laboratories CLB Cash Flow Statement (2022-2026)

NYSE CLB
$10.07 -0.08 (-0.79%)
As of: Oct 20, 2026 · 12:49 PM EDT
Reported Financials

Core Laboratories Quarterly Cash Flow Statement

Periods 17 quarters
Latest Jun 2026

Core Laboratories reported cash from operations of $7.81M and free cash flow of $3.12M for the quarter ended Jun 2026, down 43.9% year over year. This cash flow statement covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income 7.16M7.65M6.69M2.44M22.93M9.22M2.43M3.49M9.19M12.00M7.47M0.07M10.67M14.52M5.13M-0.75M5.80M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 4.36M4.17M4.07M4.04M3.94M3.93M3.87M3.84M3.77M3.68M3.66M3.72M3.67M3.59M3.67M3.76M3.83M
Share-based CompensationStock Comp. 2.23M0.30M8.98M1.35M2.07M1.57M4.82M-0.13M-0.48M-0.46M4.16M0.54M1.33M1.11M5.03M0.90M
Deferred Taxes -2.34M2.24M0.94M-11.89M-3.81M3.95M2.83M-3.60M0.88M0.57M-1.82M-1.35M-1.41M5.99M-3.72M3.72M
Asset Writedowns and ImpairmentWritedown 1.02M0.13M0.58M1.11M1.82M0.64M0.98M0.81M-0.17M0.18M0.25M
Other non-cash itemsOther Non-Cash 0.52M-0.44M-0.20M-0.29M0.78M0.29M-0.38M0.10M0.54M-0.07M0.87M-0.36M0.34M3.25M-0.73M0.62M
Change in Working Capital
Change in ReceivablesChange Receivables 1.19M6.69M4.02M-3.92M-2.98M5.49M6.29M0.73M2.44M-5.85M6.61M-2.89M-3.10M4.34M-5.01M0.39M
Change in InventoryChange Inventory 2.36M5.67M6.90M4.32M3.40M-1.64M-0.99M-0.31M-3.89M-4.17M0.27M1.72M-0.72M-3.91M3.46M0.44M
Change in Account PayablesChange Payables -0.77M11.09M-7.08M-1.61M-4.42M0.22M-0.55M3.67M-3.49M0.89M2.97M3.68M-5.36M-0.81M2.85M0.41M
Change in Accured ExpensesChange Accured Exp. -4.48M3.86M0.59M0.54M-5.06M3.55M-2.47M6.57M-1.71M0.14M0.62M-1.50M-2.48M0.66M-0.85M-7.58M
Change in Other Operating AssetsOther Assets Change -6.52M4.28M2.44M2.50M0.47M-3.91M2.80M3.05M1.90M1.03M-2.17M3.93M1.24M0.09M1.05M1.15M
Change in Other Operating LiabilitiesOther Liabilities Change -4.09M2.18M-0.54M-3.35M-2.17M1.78M0.29M0.48M3.21M1.03M-0.57M1.03M-0.74M-8.23M-2.73M2.34M
Other Working Capital ChangesOther WC Changes 2.42M-2.10M-2.98M-5.85M-2.64M5.69M-2.51M-2.57M1.31M-0.01M1.61M-2.91M-1.97M-8.31M-3.77M1.19M
Cash from OperationsCash from Ops. 5.85M13.21M-3.17M8.74M-0.21M19.43M5.53M17.15M13.10M20.62M6.66M13.92M8.50M7.95M3.97M7.81M
Investing Activities
Capital ExpendituresCapex 3.20M2.70M2.02M2.21M2.18M3.46M2.74M3.05M2.87M2.73M3.24M2.79M3.47M2.01M2.94M3.45M4.69M
Sales of Property, Plant and EquipmentPP&E (Sale) 0.15M1.46M0.08M0.27M0.07M0.07M0.59M0.21M0.13M0.80M1.23M0.97M0.15M0.67M1.49M1.58M
Change in Property, Plant and EquipmentChange in PP&E -3.20M-2.56M-0.56M-2.13M-1.90M-3.39M-2.67M-2.46M-2.66M-2.60M-2.44M-1.56M-2.51M-1.85M-2.28M-1.96M-3.10M
Change in IntangiblesChange Intangibless -0.02M0.00M-0.09M0.25M-0.01M-0.23M0.00M0.00M-0.02M0.00M0.15M-0.01M0.00M
Acquisitions 0.62M
Net of Acquisitions & DivestmentsNet Acquisitions -0.62M
Other Investing ActivitiesOther investing 0.02M-1.62M-3.38M-0.81M-1.97M2.10M3.12M0.78M5.27M-0.25M
Cash from Investing ActivitiesCash from Investing -2.56M1.06M-2.04M1.22M-3.39M-2.45M-1.66M-0.69M-0.49M-3.56M0.77M-1.64M2.39M-3.75M-3.39M-3.93M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 15.00M72.00M24.00M87.00M79.00M12.00M14.00M8.00M16.00M6.00M13.00M12.00M11.00M12.00M66.00M15.00M
Long-Term Debt RepaymentsLT Debt Repayment 18.00M82.00M16.00M85.00M83.00M27.00M17.00M21.00M24.00M20.00M15.00M12.00M20.00M16.00M62.00M15.63M
Non-Current Debt -3.00M-10.00M8.00M2.00M-4.00M-15.00M-3.00M-13.00M-8.00M-14.00M-2.00M-9.00M-4.00M4.00M-0.63M
Net Debt Issuances and RepaymentsNet Debt Issuance -3.00M-10.00M8.00M2.00M-4.00M-15.00M-3.00M-13.00M-8.00M-14.00M-2.00M-9.00M-4.00M4.00M-0.63M
Change in Capital Stock
Shares Repurchased 0.15M1.59M0.00M0.20M0.22M1.78M0.04M0.16M0.20M4.90M2.02M2.74M5.01M2.66M4.00M2.69M
Net Shares Issued and RepurchasedNet Shares Issued -0.15M-1.59M0.00M-0.20M-0.22M-1.78M-0.04M-0.16M-0.20M-4.90M-2.02M-2.74M-5.01M-2.66M-4.00M-2.69M
Net Equity Issued and RepurchasedNet Equity Issued -0.15M-1.59M0.00M-0.20M-0.22M-1.78M-0.04M-0.16M-0.20M-4.90M-2.02M-2.74M-5.01M-2.66M-4.00M-2.69M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common) 0.46M0.46M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.46M0.46M
Dividends Paid - Common and PrefferdDiv Paid (Total) 0.46M0.46M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.46M0.46M
Other financing activitiesOther financing -2.10M-0.52M-1.47M-1.38M-1.30M-1.23M-0.57M-0.05M-0.16M0.01M0.01M-1.98M0.00M-0.19M
Cash from Financing ActivitiesCash from Financing -5.71M-12.57M6.06M-0.04M-5.99M-18.48M-4.08M-13.68M-8.83M-19.37M-4.48M-3.20M-16.45M-7.12M-0.46M-3.96M
Additional items
Change in Cash -2.42M1.70M0.86M9.92M-9.59M-1.50M-0.21M2.78M3.78M-2.32M2.95M9.08M-5.56M-2.93M0.12M-0.08M
Ending Cash Balance 16.15M13.73M15.43M16.29M26.20M16.62M15.12M14.91M17.70M21.47M19.16M22.11M31.19M25.63M22.70M22.82M22.74M
Free Cash FlowFCF -3.20M3.15M11.19M-5.38M6.57M-3.67M16.69M2.48M14.28M10.37M17.37M3.88M10.45M6.50M5.00M0.52M3.12M
Net Cash FlowNCF -2.42M1.70M0.86M9.92M-9.59M-1.50M-0.21M2.78M3.78M-2.32M2.95M9.08M-5.56M-2.93M0.12M-0.08M
Interest Paid 2.74M2.20M2.96M2.23M3.15M2.86M3.29M2.51M2.94M2.12M2.26M1.81M2.49M1.63M2.88M1.44M
Income Taxes PaidTaxes Paid 3.51M3.60M1.54M3.15M11.32M-1.48M2.65M3.56M5.68M5.69M1.02M3.86M4.66M9.20M2.97M3.58M

Core Laboratories Cash Flow Statement API

Pull Core Laboratories's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY